JP7601779B2 - 層状構造を有する打錠カンナビノイドチューインガム - Google Patents

層状構造を有する打錠カンナビノイドチューインガム Download PDF

Info

Publication number
JP7601779B2
JP7601779B2 JP2021547498A JP2021547498A JP7601779B2 JP 7601779 B2 JP7601779 B2 JP 7601779B2 JP 2021547498 A JP2021547498 A JP 2021547498A JP 2021547498 A JP2021547498 A JP 2021547498A JP 7601779 B2 JP7601779 B2 JP 7601779B2
Authority
JP
Japan
Prior art keywords
chewing gum
layer
cannabinoids
weight
gum composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021547498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521711A (ja
JPWO2020177819A5 (https=
JP2022521711A5 (https=
Inventor
ハイジ・ツィーグラー・ブルーン
ドゥールト・シャキンガー・ボーセン
アン・エリクセン
Original Assignee
ノルディックカン・アー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA3035400A external-priority patent/CA3035400C/en
Priority claimed from US16/289,770 external-priority patent/US10799450B2/en
Application filed by ノルディックカン・アー／エス filed Critical ノルディックカン・アー／エス
Publication of JP2022521711A publication Critical patent/JP2022521711A/ja
Publication of JPWO2020177819A5 publication Critical patent/JPWO2020177819A5/ja
Publication of JP2022521711A5 publication Critical patent/JP2022521711A5/ja
Application granted granted Critical
Publication of JP7601779B2 publication Critical patent/JP7601779B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
    • A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021547498A 2019-03-01 2019-10-10 層状構造を有する打錠カンナビノイドチューインガム Active JP7601779B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/289,770 2019-03-01
CA3035400A CA3035400C (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
US16/289,770 US10799450B2 (en) 2019-03-01 2019-03-01 Tableted cannabinoid chewing gum with layered structure
CA3,035,400 2019-03-01
PCT/DK2019/050308 WO2020177819A1 (en) 2019-03-01 2019-10-10 Tableted cannabinoid chewing gum with layered structure

Publications (4)

Publication Number Publication Date
JP2022521711A JP2022521711A (ja) 2022-04-12
JPWO2020177819A5 JPWO2020177819A5 (https=) 2022-10-18
JP2022521711A5 JP2022521711A5 (https=) 2022-10-18
JP7601779B2 true JP7601779B2 (ja) 2024-12-17

Family

ID=68617969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547498A Active JP7601779B2 (ja) 2019-03-01 2019-10-10 層状構造を有する打錠カンナビノイドチューインガム

Country Status (9)

Country Link
EP (2) EP3876744B1 (https=)
JP (1) JP7601779B2 (https=)
CN (1) CN113423279A (https=)
AU (1) AU2019432306B2 (https=)
BR (1) BR112021012489A2 (https=)
ES (1) ES2970150T3 (https=)
MX (1) MX2021008938A (https=)
WO (1) WO2020177819A1 (https=)
ZA (1) ZA202104509B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12383591B2 (en) * 2019-11-12 2025-08-12 London Pharmaceuticals And Research Corporation Chewing gum containing synergistic medicinal compounds
WO2024227046A2 (en) * 2023-04-28 2024-10-31 Whelpley Gordon Brittain Iii Spray application of water-soluble actives to drinking vessels and other objects

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532801A (ja) 2002-07-15 2005-11-04 バゲル‐ソレンセン、アンド、カンパニー、アクティーゼルスカブ 錠剤加工されたチューインガム菓子
US20060039872A1 (en) 2004-08-06 2006-02-23 Gumlink A/S Layered chewing gum tablet
WO2006063189A2 (en) 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
JP2006520751A (ja) 2003-02-20 2006-09-14 ヤゴテック アーゲー 多層タブレット型チューインガム
WO2009080020A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
WO2009120080A1 (en) 2008-03-26 2009-10-01 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
JP2010252816A (ja) 2010-08-23 2010-11-11 Gumlink As 圧縮チューインガムタブレット
JP2015535827A (ja) 2012-09-21 2015-12-17 マイラン・インコーポレーテッド 経皮ドラッグデリバリーデバイス
US20160220593A1 (en) 2015-02-02 2016-08-04 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
WO2017059859A1 (en) 2015-10-07 2017-04-13 Medcan Pharma A/S Medical chewing gum comprising cannabinoid
US20170265494A1 (en) 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol
WO2017202424A1 (en) 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US20180147141A1 (en) 2016-11-29 2018-05-31 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71919A1 (https=) * 1975-02-26 1977-01-06
EP1554935A1 (en) * 2004-01-19 2005-07-20 Gumlink A/S Layered chewing gum tablet

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005532801A (ja) 2002-07-15 2005-11-04 バゲル‐ソレンセン、アンド、カンパニー、アクティーゼルスカブ 錠剤加工されたチューインガム菓子
JP2006520751A (ja) 2003-02-20 2006-09-14 ヤゴテック アーゲー 多層タブレット型チューインガム
US20060039872A1 (en) 2004-08-06 2006-02-23 Gumlink A/S Layered chewing gum tablet
WO2006063189A2 (en) 2004-12-10 2006-06-15 Novartis Ag Multi-layered chewing gum tablet with quick disintegration layer
WO2009080020A1 (en) 2007-12-20 2009-07-02 Fertin Pharma A/S Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet
WO2009120080A1 (en) 2008-03-26 2009-10-01 Mareda Holding Bv Chewing gum compositions comprising cannabinoids
JP2010252816A (ja) 2010-08-23 2010-11-11 Gumlink As 圧縮チューインガムタブレット
JP2015535827A (ja) 2012-09-21 2015-12-17 マイラン・インコーポレーテッド 経皮ドラッグデリバリーデバイス
US20160220593A1 (en) 2015-02-02 2016-08-04 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
WO2017059859A1 (en) 2015-10-07 2017-04-13 Medcan Pharma A/S Medical chewing gum comprising cannabinoid
WO2017202424A1 (en) 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US20180147141A1 (en) 2016-11-29 2018-05-31 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
US20170265494A1 (en) 2017-06-05 2017-09-21 International Consolidated Companies, Inc. Chewing gum including nanozome encapsulated cannabidiol

Also Published As

Publication number Publication date
ZA202104509B (en) 2023-12-20
EP3876744A1 (en) 2021-09-15
EP4306105A3 (en) 2024-04-10
EP3876744B1 (en) 2023-12-06
EP4306105A2 (en) 2024-01-17
AU2019432306B2 (en) 2023-01-05
JP2022521711A (ja) 2022-04-12
BR112021012489A2 (pt) 2021-10-26
EP3876744C0 (en) 2023-12-06
MX2021008938A (es) 2021-08-24
AU2019432306A1 (en) 2021-07-08
WO2020177819A1 (en) 2020-09-10
ES2970150T3 (es) 2024-05-27
CN113423279A (zh) 2021-09-21

Similar Documents

Publication Publication Date Title
US12582602B2 (en) Tableted cannabinoid chewing gum with tableted modules
US10933017B2 (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
JP7601779B2 (ja) 層状構造を有する打錠カンナビノイドチューインガム
JP7531500B2 (ja) ポリ酢酸ビニルエラストマー可塑剤を含む打錠カンナビノイドチューインガム
US11471405B2 (en) Tableted chewing gum with enhanced delivery of cannabinoids
US11253473B2 (en) Method of producing tableted cannabinoid chewing gum
AU2019433058B2 (en) Tableted cannabinoid chewing gum with improved release
CN113365503A (zh) 具有高强度甜味剂的大麻素口香糖
CA3035381C (en) Tableted cannabinoid chewing gum with improved release
EP3930473B1 (en) Method of producing tableted cannabinoid chewing gum
CA3035390C (en) Tableted chewing gum with enhanced delivery of cannabinoids
JP7457719B2 (ja) 糖アルコールを含むカンナビノイドチューインガム
CA3035409C (en) Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
CA3035400C (en) Tableted cannabinoid chewing gum with layered structure
US20200276118A1 (en) Tableted cannabinoid chewing gum with improved release
WO2020177822A1 (en) Tableted chewing gum with enhanced delivery of cannabinoids

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221007

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230908

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231010

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240805

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241205

R150 Certificate of patent or registration of utility model

Ref document number: 7601779

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150